Skip NavigationFDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website
FDA Home Page | CDRH Home Page | Search | A-Z Index U.S. Food and Drug AdministrationCenter for Devices and Radiological Health Questions?
horizonal rule
Consumer (CDRH/FDA) (Consumer Photo Montage)
Skip Consumer NavigationConsumer Home Product Information Choosing a Medical Device How We Can Help Resources Problems with Medical Devices

(See Related Information) New Device Approval

ArteFill® - P020012

This is a brief overview of information related to FDA's approval to market this product. See the links below to the Summary of Safety and Effectiveness and product labeling for more complete information on this product, its indications for use, and the basis for FDA's approval.


Product Name: ArteFill®
PMA Applicant: Artes Medical, Inc.
Address: 4660 La Jolla Village Drive, Suite 825 San Diego, CA 92122
Approval Date: October 27, 2006
Approval Letter: http://www.fda.gov/cdrh/pdf2/p020012a.pdf

What is it? ArteFill® is a filler that is injected into the nasolabial folds around the mouth to smooth these wrinkles. The device contains small polymethylmethacrylate beads, collagen and lidocaine.

How does it work? ArteFill® works by adding volume to nasolabial folds and restoring a smoother appearance.

When is it used? ArteFill® is injected by a doctor into the facial tissue around the mouth (i.e., nasolabial folds). The device adds volume to the skin and can give the appearance of a smoother surface.

What will it accomplish? ArteFill® will help smooth nasolabial folds around the mouth. In a clinical study most patients needed more than one injection to achieve optimal wrinkle smoothing. The average number of treatment sessions was 2.28.

Side effects of ArteFill® include:

When should it not be used? ArteFill® should not be used in patients who have:

ArteFill® should not be used for:

Additional information: The Summary of Safety and Effectiveness and labeling will be available at: http://www.fda.gov/cdrh/pdf2/p020012.html

Updated January 10, 2007

horizonal rule

CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

Center for Devices and Radiological Health / CDRH